Stryker Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Free-Cash-Flow-To-Equity" stands at 4.96 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Stryker Corporation's third quarter result of 1.35 Billion USD for the item "Free Cash Flow To Equity" represents an increase of 382.86 percent compared to it's second quarter result.
Also, Stryker Corporation's third quarter result of 1.35 Billion USD for the item "Free Cash Flow To Equity" represents a decrease of -68.43 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Stryker Corporation's third quarter result of 4.96 Billion USD for the item "Free Cash Flow To Equity" represents a decrease of -37.11 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.92 percent compared to the value the year prior.
The 1 year change in percent is 25.92.
The 3 year change in percent is 89.29.
The 5 year change in percent is -25.80.
The 10 year change in percent is 4,255.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Free Cash Flow To Equity | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Free Cash Flow To Equity | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Free Cash Flow To Equity | 172,241,486,586.05 |
![]() | Danaher Corporation - Free Cash Flow To Equity | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Free Cash Flow To Equity | 144,567,730,176.00 |